REKVINA LABORATORIES LTD. Share Price

REKVINA LABORATORIES LTD. Share Price

BSE: 526075
|
Trading
|
S Cap
₹ 35.51
+₹1.69 (5.00%)
1D
Last updated 13 Aug, 2026, 14:17 IST

REKVINA LABORATORIES LTD. Share Price Today

As of 14 Aug 2026, REKVINA LABORATORIES LTD. share price is ₹35.51. The stock opened at ₹35.51, compared to its previous close of ₹33.82. During today's trading session, REKVINA LABORATORIES LTD. share price moved in the range of ₹35.51 to ₹35.51, with an average price of ₹35.51 for the day. Looking at its last 52-week, the stock has touched a low of ₹6.75 and a high of ₹46.65.

₹35.51
5.00% up today
₹35.51
1D LOW
1D HIGH

REKVINA LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹33.74
₹37.28
52-week
L
H
₹6.75
₹46.65

About REKVINA LABORATORIES LTD.

REKVINA LABORATORIES LTD. Share Price
ISIN
INE092O01028
Sector Market Cap
₹ 39.47 Cr

REKVINA LABORATORIES LTD. Financial Highlights

  • Revenue: REKVINA LABORATORIES LTD. reported revenue of ₹1.27 crore in FY26 vs ₹0.00 crore in FY25.
  • Operating Profit: REKVINA LABORATORIES LTD. reported an operating loss of ₹0.25 crore in FY26 vs ₹0.14 crore in FY25. It showed a decrease of 78.57% on a year-on-year basis.
  • Net Profit: REKVINA LABORATORIES LTD. reported a net loss of ₹0.25 crore in FY26 vs ₹0.14 crore in FY25. It showed a decrease of 78.57% on a yearly basis.

REKVINA LABORATORIES LTD. Quarterly Result Highlights

  • REKVINA LABORATORIES LTD. reported revenue of ₹0.72 crore in Mar 2026, compared with ₹0.35 crore in Dec 2025, representing an increase of 105.71% on a quarter-on-quarter (QoQ) basis.
  • REKVINA LABORATORIES LTD. reported an operating loss of ₹0.06 crore in Mar 2026, compared with ₹0.12 crore in Dec 2025, representing an increase of 50.00% on a quarter-on-quarter (QoQ) basis.
  • REKVINA LABORATORIES LTD. reported a loss of ₹0.06 crore in Mar 2026, compared with ₹0.12 crore in Dec 2025, reflecting an increase of 50.00% on a QoQ basis.
  • The earnings per share (EPS) of REKVINA LABORATORIES LTD. stood at ₹0.23 during Mar 2026.
Know more
Promoters
41.30%
FII
0.00%
Other DII
0.00%
Retail and other
58.70%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
39.47
P/E
-80.52
P/B
0.00
ROE
20.74%
D/E
-1.20
ROCE
-104.17%
Div. Yield
0.00%
EPS(TTM)
-0.42
Turnover
1.07
EV/EBITDA
-83.51
Net Margin
0.00%
Op. Margin
0.00%
ROA
-21.01%
Quick Ratio
0.00
Curr. Ratio
0.63
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Rekvina Labs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Rekvina Labs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

REKVINA LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹0.00₹0.00₹0.00₹0.00
Total Revenue₹0.00₹0.00₹0.00₹0.00
Total Expenses₹0.14₹0.02₹0.00₹0.08
Profit Before Tax-₹0.14-₹0.02₹0.00-₹0.08
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹0.14-₹0.02₹0.00-₹0.08
EPS - Basic-₹0.23-₹0.03₹0.00-₹0.13
EPS - Diluted-₹0.23-₹0.03₹0.00-₹0.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.14-₹0.02₹0.00-₹0.08
Income before WC changes-₹0.14-₹0.02₹0.00-₹0.08
Change in Assets-₹0.01₹0.00₹0.00₹0.00
Change in Liabilities-₹0.05₹0.01₹0.01₹0.04
Change in WC-₹0.05₹0.01₹0.01₹0.04
Cash flow from Operations-₹0.19-₹0.01₹0.01-₹0.04
Cash flow from Investing₹0.00₹0.00₹0.00₹0.04
Cash flow from Financing₹0.21₹0.01₹0.00₹0.00
Total Cash Flow₹0.02₹0.00₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.01₹0.00₹0.00
Cash (End of the year)₹0.03₹0.01₹0.01₹0.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.00₹0.00₹0.19₹0.19
Current Assets₹0.03₹0.01₹0.01₹0.00
Total Assets₹0.03₹0.01₹0.20₹0.19
Current Liabilities₹0.36₹0.20₹0.19₹0.18
Net Current Asset-₹0.33-₹0.20-₹0.18-₹0.18
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital-₹0.33-₹0.20₹0.01₹0.01
Total Equity & Liabilities₹0.03₹0.01₹0.20₹0.19
* All values are in INR Crore
Qty
Bid
397
35.51
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 397
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
5
Neutral
2
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
68.19
Neutral
ATR (14)
0.96
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
52.43
Bearish
UO(9)
87.17
Bearish
ROC(12)
40.36
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
32.29
32.56
10D
29.1
30.68
20D
28.53
30.28
50D
34.27
32.75
100D
36.02
34.53
Volume trend — traded volume by day
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
REKVINA LABORATORIES LTD. Share Price
REKVINA LABORATORIES LTD.
Trading
Add Stock
Add Another

REKVINA LABORATORIES LTD. Share Price FAQs